Literature DB >> 2551341

Diagnostic implication of specific immunoglobulin G patterns of children born to HIV-infected mothers.

P A Broliden1, V Moschese, K Ljunggren, J Rosen, C Fundaro, A Plebani, M Jondal, P Rossi, B Wahren.   

Abstract

We analysed HIV-specific immunoglobulin G (IgG) responses to gag and env peptides in infants born to HIV-positive mothers. Questions of interest were whether there are early specific markers for prognosis, and whether any specific IgG is related to the prevention of vertical transmission of infection. Fifty-three children, 0-24 months old and born to HIV-1-infected mothers, were retrospectively divided into two groups based on HIV seroreactivity or non-reactivity at 15 months of age. Their sera were used to find reactivities important in diagnosis and/or prediction of the putative HIV disease. Three important findings emerged. First, a low IgG titer against the very immunodominant penv9 in newborns was found to be associated with rapid progression to AIDS. This difference was clearly reflected in the reactivity to a small peptide representing amino acid (aa) 598-606. The second interesting finding was the putative hypervariable loop on gp120 (especially aa 324-338), reactivity to which was found only in the uninfected group, and was seen in six out of 19 uninfected children under 6 months of age. This specific response was not caused by a generally high total anti-HIV reactivity, and may indicate a role of protective antibodies against vertical transmission. The response to this region in the infected group, on the other hand, was directed to the amino terminal half of the putative loop, in particular peptide 53, aa 304-318. Finally, response to a part of the amino terminal end of P17 was seen in seven out of eight infected children over 6 months of age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551341     DOI: 10.1097/00002030-198909000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

1.  Immunoblotting analysis of IgA and IgM antibody to human immunodeficiency virus type 1 (HIV-1) polypeptides in seropositive infants.

Authors:  M C Re; G Furlini; M Vignoli; G Zauli; P Dallacasa; M Masi; M La Placa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

2.  Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1.

Authors:  F J David; B Autran; H C Tran; E Menu; M Raphael; P Debre; B L Hsi; T G Wegman; F Barre-Sinoussi; G Chaouat
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

Review 3.  Antibodies for prevention of mother-to-child transmission of HIV-1.

Authors:  Genevieve G Fouda; M Anthony Moody; Sallie R Permar
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

4.  Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.

Authors:  K E Ugen; J J Goedert; J Boyer; Y Refaeli; I Frank; W V Williams; A Willoughby; S Landesman; H Mendez; A Rubinstein
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.

Authors:  Y Devash; T A Calvelli; D G Wood; K J Reagan; A Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope.

Authors:  M Ohlin; J Hinkula; P A Broliden; R Grunow; C A Borrebaeck; B Wahren
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

7.  Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission.

Authors:  S L Lamers; J W Sleasman; J X She; K A Barrie; S M Pomeroy; D J Barrett; M M Goodenow
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) Ficoll.

Authors:  S Schwander; M Opravil; R Lüthy; D G Hanson; J Schindler; A Dawson; B Letwin; M Dietrich
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

9.  Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo.

Authors:  S L Lamers; J W Sleasman; J X She; K A Barrie; S M Pomeroy; D J Barrett; M M Goodenow
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 10.  Maternal Intervention to Prevent Mother-to-Child Transmission of HIV: Moving Beyond Antiretroviral Therapy.

Authors:  Jesse F Mangold; Ria Goswami; Ashley N Nelson; David R Martinez; Genevieve G Fouda; Sallie R Permar
Journal:  Pediatr Infect Dis J       Date:  2021-05-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.